Analysing aspirin
6 Nov, 09 | by BMJ Group
BMJ deputy editor Trish Groves interviews Ike Iheanacho, editor of Drug and Therapeutics Bulletin, about its report on the use of aspirin as a primary preventative. Kirsten Patrick, an associate editor at the BMJ, talks to Charis Eng from the Cleveland Clinic about the growth in commercially available genomic screening tests. And Sabreena Malik, clinical community editor of doc2doc, BMJ Group’s clinical community site, takes us through this week’s news.
See also;
Aspirin for primary prevention of cardiovascular disease?
A practical guide to interpretation and clinical application of personal genomic screening
Analysing aspirin [19:24m]:
